Center for Improving Patient and Population Health

Discovery to implementation

Gears with words "discovery, intervention and impact" Launched in 2017 under the directorship of Christopher R. Friese Ph.D., RN, AOCN®, FAAN, the Center for Improving Patient and Population Health (CIPPH) works to address the most vexing problems faced by patients and vulnerable populations.

Projects at CIPPH span the continuum from discovery to intervention development to implementation studies. Research in these three areas, when combined, transform outcomes for individual patients and populations.

Investigators work within and outside of health care settings. Health problems don't stop when patients exit their health care institution's door, and neither do our solutions.

Read more about the development of this transformative research center and improving patient and population health.

Collective orientation

Researchers at CIPPH use a nursing lens with diverse backgrounds, scientific expertise, and interdisciplinary approaches.

CIPPH members have expertise in

nursing
medicine
health policy
management and organizations
social science
statistics and study design

Approaches to finding these solutions include

big data and analytics
mHealth
survey research
simulation
complex intervention development and evaluation
dissemination and implementation
mixed methods

T-32 in Cancer Care Delivery

The University of Michigan is poised to prepare pre and postdoctoral trainees as independent scientists who measure and ultimately improve cancer care delivery. Ranked first nationally among public universities in research volume and committed to diverse, equitable and inclusive training, the University of Michigan and the Rogel Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, provides an extraordinary environment to prepare the next generation of scientists focused on cancer care delivery.

Deadlines

While applications will be accepted on a rolling basis, priority consideration will be given to applications received by November 1 of each year.
Fellowship appointments begin: Monday, July 1 of each year.

View a list of mentoring faculty and get to know the current and former fellows. Questions about the T-32 in Cancer Care Delivery? Send an email to [email protected].

Focal areas

Cancer - To improve the experience of patients with cancer and their caregivers, an emphasis of CIPPH is improving symptom management and outcomes for patients receiving chemotherapy.
Complex needs - Patients with complex needs include those who seek care across multiple settings, or who are in critical care units, and/or those with multiple chronic conditions. CIPPH members work towards the implementation of evidence-based interventions to deliver high-quality, high-value care.
Vulnerable communities - CIPPH addresses health equity through population health studies. Current investigations include novel web-based interventions to improve hearing health among youth residing in rural areas and a novel audit and feedback intervention to reduce hazardous drug exposures among oncology nurses.

Current projects

Michigan Nurses' Study - In 2022, CIPPH launched a comprehensive study of nursing workforce issues in the state of Michigan. Learn more about Michigan Nurses' Study results.

Partners

CIPPH collaborates with a number of units at the School of Nursing and across campus. Among them are:
Institute for Healthcare Policy and Innovation
University of Michigan Rogel Cancer Center
Center for Occupational Health and Safety Engineering
Michigan Center for Integrative Research in Critical Care
School of Nursing Health Analytics Collaboratory
Michigan Institute for Data Science

Leadership

Christopher Friese, Ph.D., RN, AOCN®, FAAN

Elizabeth Tone Hosmer Professor of Nursing

Associate Director for Cancer Control and Population Sciences University of Michigan Rogel Cancer Center

Dr. Friese's program of research is focused on understanding and improving health care delivery in high-risk settings such as cancer. He continues to practice clinically as a staff nurse in hematological malignancies and advanced cancers. He currently leads three federally-funded research projects to understand and improve the safety and quality of chemotherapy care across diverse ambulatory oncology settings.